Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home
News
Italy’s ban on cultivated meat could set the industry back

From TechCrunch

By Christine Hall

March 28, 2023

Italy’s ban on cultivated meat could set the industry back

Just when the U.S. government was getting more comfortable with the concept of cultivated meat, the Italian government put forth a bill banning the use of lab-grown food.

The process of making cultivated meat includes a method, like precision fermentation in a laboratory, that uses animal cells without slaughtering the animals.

Reuters reported that the bill “aims to safeguard the country’s agri-food heritage,” according to the country’s agriculture minister, Francesco Lollobrigida, who also said, “Laboratory products in our opinion do not guarantee quality, well-being and the protection of our culture, our tradition.”

The bill will now go in front of parliament, and if passed, any violation of the law in the future could result in fines of up to €60,000, or about $65,000.

In a response to the proposed ban, Cellular Agriculture Europe called it “bad public policy,” and that it would “reduce consumers’ ability to choose the food they want,” especially new products for those “who are concerned about animal welfare and the environmental impact of their food.”

Currently, Singapore is the only country allowing sales of cultivated chicken. Good Meat was the first company to get approval to sell its cultivated chicken product there and received a U.S. Food and Drug Administration clearance last week, joining Upside Foods, as the only two companies to move to the next stage of commercializing their products in the U.S.

Dozens of companies, both in the U.S. and elsewhere, are not far behind in getting cultivated, or cell-cultured, meat products on the market. In the U.S., these companies have to receive approval from both the FDA and U.S. Department of Agriculture before commercializing their products in this country.

If you have a juicy tip or lead about happenings in the venture and food tech worlds, you can reach Christine Hall at [email protected] or Signal at 832-862-1051. Anonymity requests will be respected.

Cultivated meat is closer to our plate now that Good Meat also gets FDA blessing

Italy’s ban on cultivated meat could set the industry back by Christine Hall originally published on TechCrunch

Most Recent

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

The de-extinction startup is looking to double or triple its previous valuation, according to the report.

Jul 20, 2026

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

The one-year-old startup aims to reinvent financial architecture for autonomous AI transactions.

Jul 20, 2026

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

AI infrastructure company Infinity announced Monday a $15 million raise at a $100 million valuation from investors including Touring Capital, Principal VC, and researchers from companies such as OpenAI and Anthropic.

Jul 20, 2026

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

For the first time since 2024, StrictlyVC is coming back to New York City — and we're bringing the kind of access you’d expect from an under-wraps event to the whole startup, VC, and dealmaking community.

Jul 20, 2026

Similar Posts

This week in foodtech: Cultivated meat is still a sizzling topic

This week in foodtech: Cultivated meat is still a sizzling topic

If you’re adventurous with your food, or just like to keep up with the fast-moving foodtech industry, here’s a roundup of this week’s stories and some notable news we weren’t able to cover.

Jun 10, 2023

Cultured meat startup Higher Steaks nabs $30M and rebrands as Uncommon

Cultured meat startup Higher Steaks nabs $30M and rebrands as Uncommon

U.K.-based cultivated meat startup Higher Steaks has raised $30 million in a Series A round of funding and revealed that it’s changing its name to Uncommon. Founded out of Cambridge in 2017, Uncommon is one of countless companies pushing to make cultured “lab-grown” meat a reality in kitchens and restaurants around the globe, covering everything […]

Jun 8, 2023

Omeat emerges from stealth with beefy tech approach to cultivated meat growth media

Omeat emerges from stealth with beefy tech approach to cultivated meat growth media

Omeat's process uses regenerative factors extracted humanely from cow plasma to make growth media to create beef, pork, chicken or fish.

Jun 22, 2023

Alternative seafood startup Aqua Cultured Foods reels in $5.5M

Alternative seafood startup Aqua Cultured Foods reels in $5.5M

Aqua Cultured Foods is using proprietary mycoprotein (fungi) fermentation processes to create whole cuts of calamari, shrimp, scallops and filets of tuna and whitefish.

Apr 6, 2023

Most Recent

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

The de-extinction startup is looking to double or triple its previous valuation, according to the report.

Jul 20, 2026

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

The one-year-old startup aims to reinvent financial architecture for autonomous AI transactions.

Jul 20, 2026

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

AI infrastructure company Infinity announced Monday a $15 million raise at a $100 million valuation from investors including Touring Capital, Principal VC, and researchers from companies such as OpenAI and Anthropic.

Jul 20, 2026

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

For the first time since 2024, StrictlyVC is coming back to New York City — and we're bringing the kind of access you’d expect from an under-wraps event to the whole startup, VC, and dealmaking community.

Jul 20, 2026

Similar Posts

This week in foodtech: Cultivated meat is still a sizzling topic

This week in foodtech: Cultivated meat is still a sizzling topic

If you’re adventurous with your food, or just like to keep up with the fast-moving foodtech industry, here’s a roundup of this week’s stories and some notable news we weren’t able to cover.

Jun 10, 2023

Cultured meat startup Higher Steaks nabs $30M and rebrands as Uncommon

Cultured meat startup Higher Steaks nabs $30M and rebrands as Uncommon

U.K.-based cultivated meat startup Higher Steaks has raised $30 million in a Series A round of funding and revealed that it’s changing its name to Uncommon. Founded out of Cambridge in 2017, Uncommon is one of countless companies pushing to make cultured “lab-grown” meat a reality in kitchens and restaurants around the globe, covering everything […]

Jun 8, 2023

Omeat emerges from stealth with beefy tech approach to cultivated meat growth media

Omeat emerges from stealth with beefy tech approach to cultivated meat growth media

Omeat's process uses regenerative factors extracted humanely from cow plasma to make growth media to create beef, pork, chicken or fish.

Jun 22, 2023

Alternative seafood startup Aqua Cultured Foods reels in $5.5M

Alternative seafood startup Aqua Cultured Foods reels in $5.5M

Aqua Cultured Foods is using proprietary mycoprotein (fungi) fermentation processes to create whole cuts of calamari, shrimp, scallops and filets of tuna and whitefish.

Apr 6, 2023